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The term “desmoid” was coined by Muller in 1838 and 
is derived from the Greek word “desmos”, meaning band or 
tendon.1 Mesenteric fibromatosis accounts for approximately 
0.03% of all malignant and benign neoplasms.2 It often 
arises from the abdominal wall or the extremities of 
parous women. It can also originate, though rarely, from 
the mesentery.3 It may be locally aggressive but does 
not metastasize. Its biological behavior is similar to that 
of fibrous lesions and fibrosarcoma. The most common 
symptoms are abdominal pain, nausea, vomiting, abdominal 
mass on palpation, weight loss, and fever. The tumor may 
lead to complications such as small bowel or ureteric 
obstruction, intestinal perforation, enterocutaneous fistula, 
and intestinal hemorrhagia.4,5 
A 57-year-old male presented to our hospital with 
complaints of abdominal pain, vomiting, distension, 
and swelling. The patient had been suffering abdominal 
discomfort for five years and had undergone two 
colonoscopic examinations in those five years, but no 
disorders had been found. Abdominal examination revealed 
distension, a metallic sound, muscular rigidity, and 
tenderness. X-ray examination revealed multiple air-fluid 
levels (Figure 1). An abdominal ultrasound showed a large 
solid mass in the right upper quadrant of the abdominal 
region. Since the intravesical pressure was measured as 
25 cm H2O, the patient was diagnosed with mechanical 
intestinal obstruction, and laparotomy was performed 
following fluid and electrolyte replacement and antibiotic 
treatment. Abdominal exploration revealed an elastic hard 
tumor of 8x10 cm in diameter that appeared to originate 
from the jejunal mesentery, involving the third and fourth 
parts of the duodenum, the proximal jejunum and the 
ascending colon. The ascending colon, the proximal jejunum 
and the anterior face of the involved parts of the duodenum 
were surrounded by the mass. Thus, by right hemicolectomy, 
the first 60 cm massive small intestine and partial duodenum 
were exised to resect the mass en bloc. The proximal small 
bowel segment was anastomosed to the transverse colon 
in an end-to-side fashion, and the duodenum was sutured 
transversely. The postoperative course was uneventful, 
and the patient was allowed to go home on the eighth 
postoperative day.
Microscopic examination revealed tumor cells, showing 
infiltrative progress in adipose tissue (Figure 2). The tumor 
Figure 1 - X-ray films showing multiple air-fluid levels
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cells had pale eosinophilic cytoplasm and were embedded 
in a collagen network interrupted by fibrotic sections, but 
mitosis was not seen (Figure 3). Immunohistochemical 
analysis showed that the tumor cells expressed vimentin 
and actin (Figure 4) but not S100, desmin, CD34 or CD117. 
Macroscopic examination, microscopic examination and 
immunohistochemical features were suggestive of an 
intraabdominal desmoid tumor. 
Desmoid tumors are the most common primary tumors of 
the mesentery and constitute about 3.5% of all fibrous tissue 
tumors3,4 The difference in sex distribution is statistically 
insignificant, but there is a slightly higher incidence of 
this tumor in women than in men.7 There are two forms: 
the sporadic or primary form and the secondary form. The 
sporadic or primary form is extremely rare and is a variant 
of a benign stromal neoplasm of fibroblast-myofibroblast 
origin. It is usually secondary to trauma or hormonal 
stimulation or associated with familial polyposis coli or 
Gardner’s syndrome. Desmoid tumors have been seen in 
about 10% of familial adenomatous polyposis cases.8 At 
present, desmoid tumors are clinicopathologically classified 
into three types: abdominal, extra-abdominal and intra-
abdominal.9 Desmoids of the abdominal wall are proliferative 
fibrous tumors, and extra-abdominal desmoids (desmoids 
outside the abdominal wall) are histologically the same 
as abdominal desmoids. Extra-abdominal desmoids are 
different in that they are usually invasive and spread even 
to areas surrounding deep blood vessels and nerves; in 
addition, they are difficult to remove completely and are 
likely to recur after surgery. Trauma may be a major factor 
precipitating the onset of this type of tumor. A definite 
episode of trauma has been noted in a high percentage of 
cases (19-63%).10 Accidental blunt injuries, lacerations, 
intramuscular injections, fractures, and different endocrine 
or genetic factors have also often been implicated.11 In the 
present case, symptoms were sporadic, and the patient had 
no previous history of any of the above conditions. Imaging 
techniques such as abdominal USG and CT are the most 
useful means for determining the exact localization of the 
tumor. In CT scans, a solid lesion is observed as a mass with 
soft tissue density.12
Most mesenteric tumors are large and appear in 
women in their reproductive years, often during or after 
pregnancy.6 Regression of these tumors has been associated 
with menopause and menarche.13,14 Lim et al. investigated 
the incidence and binding characteristics of the cytosol 
estrogen receptor and found that estrogen receptors were 
present in 33% of the desmoid tumors assayed.15 The signs 
and symptoms of mesenteric fibromatosis are insidious 
and usually manifest when there is a large palpable 
tumor resulting in abdominal discomfort or pain. Weight 
loss and symptoms of ureteral obstruction, mesenteric 
ischemia, or intestinal obstruction were observed in this 
patient. Mechanical intestinal obstruction is extremely 
rare, and we have seen only one previous case in the 
literature. Gastrointestinal stromal tumors, lymphomas, 
carcinoid tumors, fibrosarcomas or inflammatory fibroid 
polyps should be considered in the differential diagnosis.16 
Histologically, desmoid tumors are composed of long 
Figure 2 - Tumoral tissue infiltrating the adipose tissue (H&Ex20)
Figure 3 - Microscopic image showing cell groups with fusiform nucleus 
that is forming bundles (H&Ex100)
Figure 4 - Severe positivity with vimentin antibody in the cell cytoplasm 
immunohistochemically
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sweeping fascicles of differentiated fibroblastic cells with ill-
defined cytoplasmic borders, delicately staining nucleoli, and 
rare mitosis. Unfortunately in some cases, the differential 
diagnosis between fibromatosis and well-differentiated 
fibrosarcoma (Grade I) is difficult.17 A variety of treatments, 
including wide surgical excision, non-steroidal anti-
inflammatory drugs, antiestrogens, radiotherapy and 
cytotoxic chemotherapy have been attempted, but the 
efficacy of most of these is unpredictable. Treatment 
modalities other than surgical excision are controversial. 
Surgery should be performed by radical resection with 
wide margins, but these tumors are often unresectable 
because of massive involvement of adjacent vital structures. 
Wide excision is recommended, as these tumors have a 
tendency toward local recurrence.1,3-7,10,12,16 The principal 
chemotherapy drugs used are vinblastine, methotrexate, 
doxorubicin, dacarbazine and carboplatin. In addition, it has 
been shown that tamoxifen, either alone or in combination 
with indomethacin, has produced a good response.1,18 Despite 
radical surgery and adjuvant radiotherapy, recurrence rates 
in most studies can be in the range of 25-50%.19 However, 
recurrent disease can be resected, and patients may live for 
extended periods with recurrent disease, especially in cases 
of sporadic desmoids. In addition, Kollevold et al. have 
reported that a desmoid tumor temporarily regressed after 
salpingo-oophorectomy in a patient with breast cancer.20 
Moreover, Baliski et al. have proposed that neoadjuvant 
treatment with doxorubicin and radiotherapy with delayed 
surgery is a better option than surgery alone.19 To the best 
of our knowledge, this is the first documented case of 
successful margin-negative resection of jejunal mesenteric 
intraabdominal fibromatosis by combined partial duodeno-
jejunectomy and right hemicolectomy. The effects of 
radiation therapy on treatment are not obvious, but several 
reports have advocated that complete regression may be 
achieved using dose levels greater than 50 Gy. Furthermore, 
Nuyttens et al. have also reported that radiotherapy or 
surgery with radiotherapy results in a significantly lower 
local recurrence rate.12,21 Objective response was seen in 
52% of patients with desmoid tumors treated with endocrine 
therapy.16 These tumors infiltrate the surrounding tissue 
and lead to severe morbidity and death. The frequency of 
local recurrence following excision is high, ranging from 
10-90%. The significance of margins is a very controversial 
topic. Some studies suggest that margins are significant for 
predicting recurrence, while others claim that they are of no 
prognostic value.22,23 The patient presented in this report had 
a small bowel obstruction caused by mesenteric fibromatosis 
and underwent only an aggressive surgical operation without 
any postoperative adjuvant therapy. The patient has shown 
no signs of recurrence at present, 30 months after surgery. As 
a result, we may say that intra-abdominal desmoids are very 
rare and benign tumors but are very aggressive and should 
be considered in the differential diagnosis of mechanical 
intestinal obstruction. 
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